Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Action of Glycation and Inflammation in Operative Ischemic Heart Disease

NCT05112731 is registered in ClinicalTrials.gov with GEK Srl as lead sponsor.

NCT NCT05112731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05112731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Action of Glycation and Inflammation in Operative Ischemic Heart Disease
Lead sponsor
GEK Srl
Phase
Observational
Overall status
Terminated
Start date
February 1, 2022
Completion date
December 31, 2023
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glycation end products, advanced, heart inflammation, heart injuries, inflammation, myocardial infarction